BioEngine Exhibited At The 2018 International Symposium On Cellular Therapy
May 25, 2018
Leave a message
Recently, the three-day 2018 (9th) International Symposium on Cell Therapy will be held in Shanghai to promote communication and cooperation in the cell therapy industry and showcase a high-end platform for technology and results. This conference has many scientific research experts, leading enterprises and clinical experts, multi-angle in-depth analysis of industrial development and trends, as well as domestic and overseas technology PK, deciphering the key points of innovative research and development, technology and product display and docking, and promote the exchange of industry elites.

The exhibition showcased the company's HIPP-T009 lymphocyte serum-free medium and Celer-S001 293 cell serum-free medium products, which attracted many customers' inquiries.


Meanwhile, this afternoon, Prof. Tan Wensong, Chairman of BioEngine, presented "Key Technology of Stem Cell/Immune Effect Cell Scale Preparation" at the conference, and actively communicated with the participants during the Q&A time after the conference, and at the same time, let the exhibitors and participants have a more comprehensive and specific understanding of BioEngine's achievements in large-scale serum-free culture technology over the years.



Through this exhibition, we further enhanced our corporate image, promoted our products, and once again conveyed BioEngine's determination to keep moving forward both inside and outside the industry, which achieved a good effect and received a good response.

